Patent ID: 7632849

Claim:
An indazolamide of formula I: wherein X is an NHC(O) or C(O)NH group, R1 is a hydrogen or halogen atom, or an aminocarbonyl, acetylamino, sulphonylmethyl, aminosulphonylmethyl, linear or branched C 1-3 alkyl or C 1-3 alkoxy group, R2 is a hydrogen atom or a linear or branched C 1-6 alkyl group or an aryl(C 1-3 )alkyl group in which the abovementioned groups are optionally substituted with one or more substituents selected from the group consisting of halogen atoms, C 1-3 alkyl and C 1-3 alkoxy, R3 and R4, which may be identical or different, are a hydrogen or halogen atom, or an amino, nitro, hydroxyl, linear or branched C 1-3 alkyl, C 1-3 alkoxy, di(C 1-3 )alkylamino, acetylamino or O—(C 1-3 )alkylphenyl group, or R3 and R4, together, form a 5- to 7-membered ring in which one or two of the said members may be a hetero atom selected from the group consisting of N, S and O, R5, R6, R7 and R8, which may be identical or different, are H or methyl; and acid-addition salts thereof with pharmaceutically acceptable organic and mineral acids.